These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma.
    Author: Vigouroux S, Gaillard F, Moreau P, Harousseau JL, Milpied N.
    Journal: Haematologica; 2005 Nov; 90(11):1580-2. PubMed ID: 16266909.
    Abstract:
    We retrospectively investigated the outcome of 30 newly diagnosed patients with mantle cell lymphoma treated with high-dose therapy and autologous stem cell transplantation in first response. With a median follow-up of 55 months, the 5-year overall-survival is 62%, the 5-year progression-free-survival is 40% and no secondary malignancy has occurred.
    [Abstract] [Full Text] [Related] [New Search]